These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

795 related items for PubMed ID: 18618969

  • 21. Reflections on historical, scientific, and legal issues relevant to designing approval pathways for generic versions of recombinant protein-based therapeutics and monoclonal antibodies.
    Dudzinski DM.
    Food Drug Law J; 2005; 60(2):143-260. PubMed ID: 16094771
    [No Abstract] [Full Text] [Related]

  • 22. American beauty: an analytical view of the past and current effectiveness of cosmetic safety regulations and future direction.
    Termini RB, Tressler L.
    Food Drug Law J; 2008; 63(1):257-74. PubMed ID: 18561461
    [No Abstract] [Full Text] [Related]

  • 23. Anticipating new consumer protection challenges in the food and drug marketplace.
    Parnes LB.
    Food Drug Law J; 2008; 63(2):593-9. PubMed ID: 18561480
    [No Abstract] [Full Text] [Related]

  • 24. Food security would be compromised by combining the Food and Drug Administration and the U.S. Department of Agriculture into a single food agency.
    Pape SM, Rubin PD, Kim H.
    Food Drug Law J; 2004; 59(3):405-16. PubMed ID: 15586990
    [No Abstract] [Full Text] [Related]

  • 25. Ephedra: yesterday, DSHEA, and tomorrow--a ten year perspective on the Dietary Supplement Health and Education Act of 1994.
    Seamon MJ, Clauson KA.
    J Herb Pharmacother; 2005; 5(3):67-86. PubMed ID: 16520299
    [Abstract] [Full Text] [Related]

  • 26. The learned intermediary doctrine: past, present and future.
    Alsobrook HB.
    Leg Med; 1994; ():269-80. PubMed ID: 7830482
    [No Abstract] [Full Text] [Related]

  • 27. Consumer-directed advertising of contraceptive drugs: the FDA, Depo-Provera, and product liability.
    Green W.
    Food Drug Law J; 1995; 50(4):553-67. PubMed ID: 10343019
    [No Abstract] [Full Text] [Related]

  • 28. Food safety inspections: a call for rational reorganization.
    DeWaal CS.
    Food Drug Law J; 1999; 54(3):453-8. PubMed ID: 11797708
    [No Abstract] [Full Text] [Related]

  • 29. Deterring inefficient pharmaceutical litigation: an economic rationale for the FDA regulatory compliance defense.
    Viscusi WK, Rowland SR, Dorfman HL, Walsh CJ.
    Spec Law Dig Health Care Law; 1996 Mar; (205):9-52. PubMed ID: 10156421
    [No Abstract] [Full Text] [Related]

  • 30. Food, drugs, and droods: a historical consideration of definitions and categories in American food and drug law.
    Grossman LA.
    Cornell Law Rev; 2008 Jul; 93(5):1091-148. PubMed ID: 18618972
    [Abstract] [Full Text] [Related]

  • 31. Unapproved drugs in the United States and the Food and Drug Administration.
    Nasr A, Lauterio TJ, Davis MW.
    Adv Ther; 2011 Oct; 28(10):842-56. PubMed ID: 21894470
    [Abstract] [Full Text] [Related]

  • 32. Vioxx's history and the need for better procedures and better testing.
    Gilhooley M.
    Seton Hall Law Rev; 2007 Oct; 37(4):941-68. PubMed ID: 18363218
    [No Abstract] [Full Text] [Related]

  • 33. The US Food and Drug Administration and probiotics: regulatory categorization.
    Degnan FH.
    Clin Infect Dis; 2008 Feb 01; 46 Suppl 2():S133-6; discussion S144-51. PubMed ID: 18181719
    [Abstract] [Full Text] [Related]

  • 34. Regulation of probiotic substances as ingredients in foods: premarket approval or "generally recognized as safe" notification.
    Mattia A, Merker R.
    Clin Infect Dis; 2008 Feb 01; 46 Suppl 2():S115-8; discussion S144-51. PubMed ID: 18181714
    [Abstract] [Full Text] [Related]

  • 35. Regulation of dietary supplements: five years of DSHEA.
    Khatcheressian LA.
    Food Drug Law J; 1999 Feb 01; 54(4):623-44. PubMed ID: 11824458
    [No Abstract] [Full Text] [Related]

  • 36. Meat! It is what you do not know that hurts you: why FDA should reevaluate the use of carbon monoxide in modified atmospheric meat packaging.
    Bailey NJ.
    Food Drug Law J; 2008 Feb 01; 63(4):735-51. PubMed ID: 19593921
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The Food and Drug Administration's actions on ephedra and androstenedione: understanding their potential impacts on the protections of the Dietary Supplement Health and Education Act.
    Siegner AW.
    Food Drug Law J; 2004 Feb 01; 59(4):617-28. PubMed ID: 15880877
    [No Abstract] [Full Text] [Related]

  • 39. The hang-up with HACCP: the resistance to translating science into food safety law.
    Fortin ND.
    Food Drug Law J; 2003 Feb 01; 58(4):565-93. PubMed ID: 15027451
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 40.